Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Has results × Solid Neoplasms × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 274 Carcinoma, Non-Small-Cell Lung 132 Breast Neoplasms 111 Neoplasm Metastasis 90 Melanoma 81 Lymphoma 70 Leukemia, Myeloid, Acute 69 Multiple Myeloma 66 Colorectal Neoplasms 63 Ovarian Neoplasms 60 Lymphoma, Non-Hodgkin 49 Recurrence 46 Pancreatic Neoplasms 46 Prostatic Neoplasms 45 Lung Neoplasms 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Carcinoma, Renal Cell 34 Advanced Solid Tumors 34 Leukemia 33 Leukemia, Lymphocytic, Chronic, B-Cell 32 Glioblastoma 30 Lymphoma, Large B-Cell, Diffuse 29 Head and Neck Neoplasms 29 Triple Negative Breast Neoplasms 27 Myelodysplastic Syndromes 27 Stomach Neoplasms 26 Sarcoma 26 Lymphoma, Follicular 25 Brain Neoplasms 25 Urinary Bladder Neoplasms 23

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03364049 2021-11-15

MK-7162-002

Merck Sharp & Dohme LLC

Phase 1 Completed

33 enrolled 19 charts

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡